Company News
 AC Immune strengthens management, appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
                                                    AC Immune strengthens management, appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
                                                    Retiring CSO Dr. Marie Kosco-Vilbois will remain as consultant to ensure smooth handover
AC Immune strengthens management, appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
                                                    AC Immune strengthens management, appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
                                                    Retiring CSO Dr. Marie Kosco-Vilbois will remain as consultant to ensure smooth handover
                                                
                                                                                                                                                                                                                                                                                
                                         Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
                                                    Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
                                                    Experienced quality assurance professional joins team to support ongoing strategic growth plans as the Company expands access and capabilities of INDUCE-seq DNA break mapping...
Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
                                                    Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
                                                    Experienced quality assurance professional joins team to support ongoing strategic growth plans as the Company expands access and capabilities of INDUCE-seq DNA break mapping...
                                                
                                                                                                                                                                                                                                                                                
                                         Change of management at the Romaco facility in Karlsruhe
                                                    Change of management at the Romaco facility in Karlsruhe
                                                    Boris Bachmeier appointed new Managing Director of Romaco Pharmatechnik GmbH
Change of management at the Romaco facility in Karlsruhe
                                                    Change of management at the Romaco facility in Karlsruhe
                                                    Boris Bachmeier appointed new Managing Director of Romaco Pharmatechnik GmbH
                                                
                                                                                                                                                                                                                                                                                
                                         Aptar Digital Health expands oncology clinical advisory board
                                                    Aptar Digital Health expands oncology clinical advisory board
                                                    Aptar Digital Health announces the expansion of its oncology clinical advisory board.
Aptar Digital Health expands oncology clinical advisory board
                                                    Aptar Digital Health expands oncology clinical advisory board
                                                    Aptar Digital Health announces the expansion of its oncology clinical advisory board.
                                                
                                                                                                                                                                                                                                                                                
                                         Cherwell welcomes new recruits as pharma environmental monitoring needs grow
                                                    Cherwell welcomes new recruits as pharma environmental monitoring needs grow
                                                    Autumn 2023 sees five new starters across Cherwell’s expanding business to support continuing business growth in cleanroom microbiology
Cherwell welcomes new recruits as pharma environmental monitoring needs grow
                                                    Cherwell welcomes new recruits as pharma environmental monitoring needs grow
                                                    Autumn 2023 sees five new starters across Cherwell’s expanding business to support continuing business growth in cleanroom microbiology
                                                
                                                                                                                                                                                                                                                                                
                                         New expert advisory board appointments set to drive growth and innovation at Hongene
                                                    New expert advisory board appointments set to drive growth and innovation at Hongene
                                                    Hongene, a leading biotech company in the nucleic acid manufacturing sector, has launched a new advisory board with international experts from academia and industry. This...
New expert advisory board appointments set to drive growth and innovation at Hongene
                                                    New expert advisory board appointments set to drive growth and innovation at Hongene
                                                    Hongene, a leading biotech company in the nucleic acid manufacturing sector, has launched a new advisory board with international experts from academia and industry. This...
                                                
                                                                                                                                                                                                                                                                                
                                         Myricx Bio appoints Dr Chris Martin as Chair of its Board of Directors
                                                    Myricx Bio appoints Dr Chris Martin as Chair of its Board of Directors
                                                    Dr Martin is a renowned biotech company founder, director and entrepreneur, and a pioneer and leader in the ADC space
Myricx Bio appoints Dr Chris Martin as Chair of its Board of Directors
                                                    Myricx Bio appoints Dr Chris Martin as Chair of its Board of Directors
                                                    Dr Martin is a renowned biotech company founder, director and entrepreneur, and a pioneer and leader in the ADC space
                                                
                                                                                                                                                                                                                                                                                
                                         Axplora announces the appointment of its Scientific Advisory Board
                                                    Axplora announces the appointment of its Scientific Advisory Board
                                                    This SAB plays a key role in setting market trends and shaping Axplora Research & Development (R&D) activities, while supporting the deployment of innovative technologies and...
Axplora announces the appointment of its Scientific Advisory Board
                                                    Axplora announces the appointment of its Scientific Advisory Board
                                                    This SAB plays a key role in setting market trends and shaping Axplora Research & Development (R&D) activities, while supporting the deployment of innovative technologies and...
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                         Christian Praxmarer becomes new CEO of Single Use Support
                                                    Christian Praxmarer becomes new CEO of Single Use Support
                                                    Former Managing Director and COO, Christian Praxmarer, will become the new CEO of Single Use Support on 15 November
Christian Praxmarer becomes new CEO of Single Use Support
                                                    Christian Praxmarer becomes new CEO of Single Use Support
                                                    Former Managing Director and COO, Christian Praxmarer, will become the new CEO of Single Use Support on 15 November
                                                
                                                                                                                                                                                                                                                                                
                                         Management changes at EyeC: Markus Fietkau is the new Sales Director
                                                    Management changes at EyeC: Markus Fietkau is the new Sales Director
                                                    Markus Fietkau will be responsible for sales management, whereas Ralph Beier will support the department as Business Development Director
Management changes at EyeC: Markus Fietkau is the new Sales Director
                                                    Management changes at EyeC: Markus Fietkau is the new Sales Director
                                                    Markus Fietkau will be responsible for sales management, whereas Ralph Beier will support the department as Business Development Director
                                                
                                                                                                                                                                                                                                                                                
                                         SENISCA strengthens board with the appointment of Dr David Chiswell as Chair
                                                    SENISCA strengthens board with the appointment of Dr David Chiswell as Chair
                                                    Highly experienced biotech veteran to support SENISCA’s rapid development of its senotherapeutic platform
SENISCA strengthens board with the appointment of Dr David Chiswell as Chair
                                                    SENISCA strengthens board with the appointment of Dr David Chiswell as Chair
                                                    Highly experienced biotech veteran to support SENISCA’s rapid development of its senotherapeutic platform
                                                
                                                                                                                                                                                                                                                                                
                                         IO Biotech appoints Helen Collins, MD, to its board of directors
                                                    IO Biotech appoints Helen Collins, MD, to its board of directors
                                                    Dr Collins is an industry veteran with significant experience in oncology/haematology drug development and will serve on the Research and Development Committee of the board
IO Biotech appoints Helen Collins, MD, to its board of directors
                                                    IO Biotech appoints Helen Collins, MD, to its board of directors
                                                    Dr Collins is an industry veteran with significant experience in oncology/haematology drug development and will serve on the Research and Development Committee of the board
                                                
                                                                                                                                                                                                                                                                                
                                         Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today
                                                    Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today
                                                    Oncopeptides AB, a biotech company focused on difficult to treat cancers, today announces that Henrik Bergentoft today takes office as the company´s new Chief Financial Officer
Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today
                                                    Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today
                                                    Oncopeptides AB, a biotech company focused on difficult to treat cancers, today announces that Henrik Bergentoft today takes office as the company´s new Chief Financial Officer
                                                
                                                                                                                                                                                                                                                                                
                                         TeraPore appoints Mani Krishnan as President and COO
                                                    TeraPore appoints Mani Krishnan as President and COO
                                                    He provides the team with the tools needed to bring self-assembled block copolymer membranes to customers
TeraPore appoints Mani Krishnan as President and COO
                                                    TeraPore appoints Mani Krishnan as President and COO
                                                    He provides the team with the tools needed to bring self-assembled block copolymer membranes to customers
                                                
                                                                                                                                                                                                                                                                                
                                         Coriolis Pharma re-establishes Chair in Vaccine Development at Leiden University
                                                    Coriolis Pharma re-establishes Chair in Vaccine Development at Leiden University
                                                    Leiden University has reappointed Prof. Dr Gideon Kersten to the Chair in Vaccine Development for a third 5-year term
Coriolis Pharma re-establishes Chair in Vaccine Development at Leiden University
                                                    Coriolis Pharma re-establishes Chair in Vaccine Development at Leiden University
                                                    Leiden University has reappointed Prof. Dr Gideon Kersten to the Chair in Vaccine Development for a third 5-year term
                                                
                                                                                                                                                                                                                                                                                
                                         SENISCA appoints Dr Sarah Cole as Chief Executive Officer
                                                    SENISCA appoints Dr Sarah Cole as Chief Executive Officer
                                                    SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and treat age-related disease, announces that Sarah Cole, who previously...
SENISCA appoints Dr Sarah Cole as Chief Executive Officer
                                                    SENISCA appoints Dr Sarah Cole as Chief Executive Officer
                                                    SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and treat age-related disease, announces that Sarah Cole, who previously...
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                         Axplora appoints Dr Stephan Haitz as President of its Novasep CDMO business unit
                                                    Axplora appoints Dr Stephan Haitz as President of its Novasep CDMO business unit
                                                    Axplora is delighted to welcome Dr Stephan Haitz as President of the Novasep CDMO Business Unit and member of the company’s Executive Committee (effective 1 November)
Axplora appoints Dr Stephan Haitz as President of its Novasep CDMO business unit
                                                    Axplora appoints Dr Stephan Haitz as President of its Novasep CDMO business unit
                                                    Axplora is delighted to welcome Dr Stephan Haitz as President of the Novasep CDMO Business Unit and member of the company’s Executive Committee (effective 1 November)
                                                
                                                                                                                                                                                                                                                                                
                                         Quotient Sciences appoints Thierry Van Nieuwenhove as new CEO
                                                    Quotient Sciences appoints Thierry Van Nieuwenhove as new CEO
                                                    Wayne Hewett also joins Quotient's Board of Directors as Non-Executive Chairman
Quotient Sciences appoints Thierry Van Nieuwenhove as new CEO
                                                    Quotient Sciences appoints Thierry Van Nieuwenhove as new CEO
                                                    Wayne Hewett also joins Quotient's Board of Directors as Non-Executive Chairman
                                                
                                                                                                                                                                                                                                                                                
                                         Broughton appoints Dr Russ Svensen as director of consultancy services
                                                    Broughton appoints Dr Russ Svensen as director of consultancy services
                                                    His appointment will be instrumental in helping Broughton expand its consultancy service and develop its clinical service offering
Broughton appoints Dr Russ Svensen as director of consultancy services
                                                    Broughton appoints Dr Russ Svensen as director of consultancy services
                                                    His appointment will be instrumental in helping Broughton expand its consultancy service and develop its clinical service offering
                                                
                                                                                                                                                                                                                                                                                
                                         Pharmaworks announces appointment of Nathan Allen as VP and General Manager
                                                    Pharmaworks announces appointment of Nathan Allen as VP and General Manager
                                                    Allen is responsible for leading the Pharmaworks organisation, including the strategies that bring their high-performance blister packaging systems to pharmaceutical,...
                                                
                                                                                                                                                                                                                                                                                
                                        Particle Dynamics appoints Anish Parikh as new CCO
                                                    Particle Dynamics appoints Anish Parikh as new CCO
                                                    Anish Parikh, with over 25 years of experience in the consumer health, pharmaceutical, and biotech industries, joins Particle Dynamics as the new Chief Commercial Officer
Pharmaworks announces appointment of Nathan Allen as VP and General Manager
                                                    Pharmaworks announces appointment of Nathan Allen as VP and General Manager
                                                    Allen is responsible for leading the Pharmaworks organisation, including the strategies that bring their high-performance blister packaging systems to pharmaceutical,...
                                                
                                                                                                                                                                                                                                                                                
                                        Particle Dynamics appoints Anish Parikh as new CCO
                                                    Particle Dynamics appoints Anish Parikh as new CCO
                                                    Anish Parikh, with over 25 years of experience in the consumer health, pharmaceutical, and biotech industries, joins Particle Dynamics as the new Chief Commercial Officer
                                                
                                                                                                                                                                                                                                                                                
                                         Tiziana Life Sciences appoints Chief Development Officer
                                                    Tiziana Life Sciences appoints Chief Development Officer
                                                    William A. Clementi will take up the role of Chief Development Officer, which will become effective as of September 1 2023
Tiziana Life Sciences appoints Chief Development Officer
                                                    Tiziana Life Sciences appoints Chief Development Officer
                                                    William A. Clementi will take up the role of Chief Development Officer, which will become effective as of September 1 2023
                                                
                                                                                                                                                                                                                                                                                
                                         Envirogen appoints Healthcare Sales Manager Sam Blakemore
                                                    Envirogen appoints Healthcare Sales Manager Sam Blakemore
                                                    Blakemore brings several years' experience as Envirogen Project Manager working across different markets including water treatment projects in healthcare
Envirogen appoints Healthcare Sales Manager Sam Blakemore
                                                    Envirogen appoints Healthcare Sales Manager Sam Blakemore
                                                    Blakemore brings several years' experience as Envirogen Project Manager working across different markets including water treatment projects in healthcare
                                                
                                                                                                                                                                                                                                                                                
                                         ViroCell appoints Brian Collins as CFO
                                                    ViroCell appoints Brian Collins as CFO
                                                    Brian brings a wealth of relevant experience to the company as it embarks on its next phase of growth, having spent the last four years as CFO of the Cell and Gene Therapy...
ViroCell appoints Brian Collins as CFO
                                                    ViroCell appoints Brian Collins as CFO
                                                    Brian brings a wealth of relevant experience to the company as it embarks on its next phase of growth, having spent the last four years as CFO of the Cell and Gene Therapy...